HISTORY OF ESTABLISHMENT
Starting at 10 AM, a first meeting of 60 representatives of private companies and bio-tech institutions took place. The talks resulted into a more detailed plan of a further approach: organizing a survey (mapping interest of companies, the acceptability of various legal forms, suggestions for cluster activities, and mechanisms for discussing documents) between 30 September and 20 October 2008. An e-mail conference among individual potential members of the cluster was planned to take place from 20 October until 10 November.
ORGANIZATIONAL STRUCTURE
ORGANIZATIONAL STRUCTURE
ORGANIZATIONAL STRUCTURE
Board of directors
chairman
RNDr. Marek Moša, PhD. (MB PHARMA s. r. o.)
members
MUDr. Peter Bauer, PhD. (Bioinova, s. r. o.)
MVDr. Mgr. Ladislav Pažout (Dyntec spol. s. r. o.)
RNDr. Josef Boštík, CSc. (Fagofarma, s. r. o.)
The supervisory board
members
Ing. Michaela Poláková (Vidia s. r. o.)
Ing. Irena Kolouchová, PhD. (VŠCHT)
Hana Potočková, M.Sc. (Contipro, a. s.)